Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses CMPR Q1 2026 Earnings Massive EPS Beat Drives Stock Higher MH Q1 2026 Earnings EPS Surges 18455 Above Estimates Stock Retreats on Uncertain Outlook PEW Q1 2026 Earnings EPS Surprises Positively Despite Broader Market Pressure i3 Verticals Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gains